F2 and pertussis: At 2 months of age, GMCs of anti-PT, anti-PRN, and anti-FHA remained higher in the Tdap-vaccinated group (p < 0.001), suggesting that these antibodies might be contributing to the protection against pertussis on newborn infants in this period of higher morbidity and mortality.